<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="2651">Aminoacyl-tRNA</z:chebi> synthetase-interacting multifunctional proteins (AIMPs) form a protein complex with <z:chebi fb="0" ids="2651">aminoacyl-tRNA</z:chebi> synthetases </plain></SENT>
<SENT sid="1" pm="."><plain>In addition to protein translation, AIMPs play a role in diverse biological processes </plain></SENT>
<SENT sid="2" pm="."><plain>Earlier studies suggested that AIMPs may act as <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressors </plain></SENT>
<SENT sid="3" pm="."><plain>However, the expression status of the AIMP proteins in human <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> tissues is largely unknown </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we analyzed the expression of AIMP members (AIMP1, AIMP2 and AIMP3) in <z:hpo ids='HP_0012126'>gastric cancer</z:hpo> (GC) and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) tissues </plain></SENT>
<SENT sid="5" pm="."><plain>We analyzed the expression of these proteins in 100 GC and 103 CRC tissues by immunohistochemistry using a tissue microarray method </plain></SENT>
<SENT sid="6" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> gastric and colon mucosa expressed AIMP1, AIMP2 and AIMP3 in nearly <z:hpo ids='HP_0000001'>all</z:hpo> of the cases (95-100%) </plain></SENT>
<SENT sid="7" pm="."><plain>However, the expression of AIMP1, AIMP2 and AIMP3 was significantly decreased in the GC samples (60%, 52% and 70% of the cases, respectively) and in the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> samples (66%, 53% and 81% of the cases, respectively) ( P &lt;0.01) </plain></SENT>
<SENT sid="8" pm="."><plain>Expression of AIMP1, AIMP2 or AIMP3 was not associated with clinicopathological parameters including differentiation, depth of invasion and TNM stage </plain></SENT>
<SENT sid="9" pm="."><plain>The decreased expression of AIMP1, AIMP2 and AIMP3 in the GC and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> tissues compared to the corresponding <z:mpath ids='MPATH_458'>normal</z:mpath> tissues suggested that downregulation of these proteins may be related to inactivation of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> suppressor functions of AIMP proteins and might play a role in the development of GC and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
</text></document>